Emerging Therapeutic Strategies for Overcoming Proteasome Inhibitor Resistance-Reference-Cited by-同舟云学术

Emerging Therapeutic Strategies for Overcoming Proteasome Inhibitor Resistance

Published:2015 Issue: Volume: Page:191-226
ISSN:0065-230X
Container-title:Advances in Cancer Research
language:
Short-container-title:

Author:

Dolloff Nathan G.

Publisher

Elsevier

Reference193 articles.

1. The proteasome: A suitable antineoplastic target;Adams;Nature Reviews. Cancer,2004

2. Regulation of JNK signaling by GSTp;Adler;The EMBO Journal,1999

3. Promiscuous MYC locus rearrangements hijack enhancers but mostly super-enhancers to dysregulate MYC expression in multiple myeloma;Affer;Leukemia,2014

4. Inhibition of constitutive STAT3 activity sensitizes resistant non-Hodgkin's lymphoma and multiple myeloma to chemotherapeutic drug-mediated apoptosis;Alas;Clinical Cancer Research,2003

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interplay between proteasome inhibitors and NF-κB pathway in leukemia and lymphoma: a comprehensive review on challenges ahead of proteasome inhibitors;Cell Communication and Signaling;2024-02-08

2. Ubiquitin–Proteasome System as a Potential Drug Target for Malaria;Drug Targets for Plasmodium Falciparum: Historic to Future Perspectives;2024

3. Unlocking the potential of approved drugs for the allosteric inhibition of tropomyosin-receptor kinase A using molecular docking and molecular dynamics studies;Frontiers in Chemistry;2023-06-07

4. Targeted Therapies: A Molecular Overview;The Bulletin of Urooncology;2023-03-01

5. Proteasome Inhibitors and Their Potential Applicability in Osteosarcoma Treatment;Cancers;2022-09-20